Search

everythinglearnresearchcommunity

for

Search:↓

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

PCOS is a hormonal disorder causing infertility and menstrual problems, often linked to obesity and can lead to acne, treated with hormonal and insulin-sensitizing medications.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Paeonia lactiflora and Poria cocos extracts can potentially increase hair growth and reduce hair loss symptoms by lowering testosterone and inflammation levels.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Androgens prevent hair growth by changing Wnt signals in cells.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

UV-induced autofluorescence is effective for identifying different types of alopecia.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Women with a certain type of hair loss have more copper in the back of their head than the front, and treatment can normalize hair but not copper levels.

Early life factors, including a mother's health and environment, can affect the chances of developing polycystic ovary syndrome later in life.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.